Filters

Human CNTN5 Antibody

Human CNTN5 Antibody size: bulk 0

Price 0
Size bulk
Available sizes100ug:330, 50ug:198
Storestore in freezer for long therm or fridge for short time storage
Category Coli rec, ELISAs, e, human proteins, research antibodies
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Human proteins, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, C, C for long term storage and for short term at + 5°, Homo sapiens sapiens), If you buy Antibodies supplied by genways bulk they should be stored frozen at - 24°, humans , ssp
Gene targetCNTN5
Short nameCNTN5 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Species Humans, Human
Alternative name sapiens contactin 5 (Antibody to), H
Alternative techniqueantibodies
Alternative to gene target CNTN5 and IDBG-68747 and ENSG00000149972 and 53942, Cntn5 and IDBG-133869 and ENSMUSG00000039488 and 244682, Plasma membranes, protein binding, this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0007155 and cell adhesion and biological process this GO :0007605 and sensory perception of sound and biological process this GO :0031225 and anchored component of membrane and cellular component, this GO :0005515: protein binding, this GO :0005515: protein binding, contactin 5
Identity 2175
Gene CNTN5
Long gene name contactin 5
Synonyms NB-2 hNB-2
Locus 11q22, 1
Discovery year 2000-05-26
GenBank acession AB013802
Entrez gene record 53942
RefSeq identity NM_014361
Classification I-set domain containing Immunoglobulin like domain containing Fibronectin type III domain containing
Havana BLAST/BLAT OTTHUMG00000167579

Similar products

Subscribe to our Newsletter